AGNC Investment AGNC
- Market cap
- $10.5B
- PE
- 4.7×
- 10y median 8.5×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Revenue, 12 months
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Net margin
- n/m
- one or more of the four quarters through 2026-06-30 missing
AGNC Investment trades at 4.7× trailing earnings, cheaper than 88% of the last ten years.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| SG&A | $9M+13% | $8M−11% | $8M+0% | $9M+0% | $9M+0% | $10M+25% | $9M+13% | $10M+11% | $10M+11% | $11M+10% | $11M+22% | $11M+10% |
| Interest expense | $646M+230% | $666M+107% | $672M+50% | $698M+33% | $820M+27% | $741M+11% | $687M+2% | $668M−4% | $755M−8% | $738M−0% | $731M+6% | $709M+6% |
| Pre-tax income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Net income | −$392M−41% | $412M−27% | $443M | −$48M | $346M | $122M−70% | $50M−89% | −$140M+192% | $806M+133% | $954M+682% | −$148M | $654M |
| −$0.68−48% | $0.57−39% | $0.59 | −$0.11 | $0.39 | $0.10−83% | $0.02−97% | −$0.17+55% | $0.72+85% | $0.83+730% | −$0.17 | $0.52 | |
| 622M+18% | 673.6M+19% | 704.2M+22% | 740M+23% | 810.1M+30% | 886.4M+32% | 921.9M+31% | 1B+38% | 1.1B+30% | 1.1B+24% | 1.1B+22% | 1.2B+14% |
EPS, diluted: 13 periods, Q1 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 4 periods, Q4 FY20 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY23: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in REIT - Specialty nearest AGNC Investment's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| AGNCAGNC Investment | $10.5B | 4.7× | 8.5× | n/m | n/m | n/m | |
| EGPEastgroup Properties | $10.7B | 34.9× | 38.3× | 14.2× | +11% | 40.5% | |
| CPTCamden Property Trust | $10.3B | 33.8× | 43.2× | n/m | +57% | n/m | |
| BXPBXP | $9.9B | 33.4× | 37.3× | 2.8× | +2% | 8.4% | |
| AMHAmerican Homes 4 Rent | $11.5B | 25.3× | 53.9× | 6.1× | +4% | 25.5% | |
| GLPIGaming & Leisure Properties | $11.5B | 11.6× | 19.3× | 7.0× | +6% | 58.5% | |
| UDRUDR | $11.5B | 22.8× | 78.4× | 6.7× | +2% | 30.4% | |
| AHRAmerican Healthcare REIT | $11.6B | 78.0× | 116× | 4.9× | +19% | 5.2% | |
| FRTFederal Realty Investment Trust | $9.4B | 22.0× | 32.3× | 7.1× | +8% | 32.7% | |
| ELSEquity Lifestyle Properties | $11.8B | 29.5× | 43.1× | 7.6× | +3% | 26.6% | |
| CUBECubeSmart | $9B | 27.7× | 35.9× | 8.0× | +4% | 29.3% | |
| Peer median | $11.1B | 28.6× | 40.7× | 7.0× | +5% | 29.3% |
More on AGNC Investment
Each number over time
Where it ranks
Its groups
About
- Industry
- REIT - Specialty
- Sector
- Real Estate
Valuation data, not investment advice. Prices as of .